There’s a script most of us follow without ever deciding to.
You wake up, or you’re at work, or you’re twenty minutes into a run, and you feel the first pull. You wait a bit, because maybe it’s nothing. It’s not nothing. You find something to take. Then you wait for it to work, which takes a while, and in the meantime the day has already shifted around the pain.
That sequence feels like common sense: something hurts, so you treat it. But when you look at how menstrual pain actually develops, the timing is backwards — and the reason why is worth understanding.
The problem with treating a chemical after it’s been released
Recall from our earlier post: menstrual pain is driven by prostaglandins released as the uterine lining breaks down. They cause the intense, uncoordinated, high-pressure contractions that squeeze off blood flow to the uterine muscle.
Now, the medications that have been used against menstrual pain for decades work by inhibiting the enzymes that produce prostaglandins. That’s the mechanism. They shut down the assembly line.
Which is effective — and also implies something specific about timing. Shutting down production does nothing about the prostaglandins that have already been produced and are already acting on tissue. Those have to run their course.
So when you wait for pain before you act, you’ve already let a substantial amount of the driving chemical into the system. You’re not stopping the problem. You’re stopping the next round of it while the current round finishes what it started.
There’s an interesting piece of clinical evidence for how real this distinction is. When first-line options aren’t sufficient, clinicians sometimes turn to a different chemical class that both inhibits prostaglandin synthesis and blocks the action of prostaglandins already formed. The fact that this second property is considered a clinical advantage tells you the already-formed pool is a genuine problem — one worth designing around rather than around which to hope for the best.
What the evidence says about starting early
This isn’t a novel or fringe idea. It’s standard clinical guidance, and it’s been studied for a long time.
The instruction clinicians give is to begin one to two days before the expected onset of menstrual pain, and to continue on a schedule — around the clock — through the first day or two, rather than taking something only when the pain becomes noticeable. The stated rationale is exactly the one above: these medications are most effective when started early, because of how they act on the enzymes that generate the pain in the first place.
The efficacy data is strong. Across randomized trials, roughly 70 to 90 percent of adults and adolescents get effective pain relief — meaningfully better than placebo.
And the mechanism has been confirmed rather than just inferred. When women are treated, their symptom improvement runs in parallel with measurable drops in intrauterine pressure and in prostaglandin levels in menstrual fluid. The pain goes down because the thing causing it goes down. You can watch it happen on the instruments.
Why almost nobody does it this way
If the guidance is this clear, why is “wait until it hurts” the near-universal default?
A few reasons, none of them good.
The instructions on most packaging are written for general aches, where waiting for symptoms makes perfect sense. Nobody takes something on Tuesday for a headache they expect Thursday. The pre-emptive approach is specific to a pain with a predictable trigger, and general labeling has no reason to describe it.
There’s also a conversation that mostly doesn’t happen. Menstrual pain is recognized in the clinical literature as both underdiagnosed and undertreated — one reason clinicians are urged to ask about it proactively rather than wait for patients to raise it. Among adolescents with menstrual pain, only about 15 percent seek medical advice for it. If the conversation never happens, the guidance never gets passed along.
And underneath both of those is a cultural default that period pain is something you get through rather than something you address. That assumption has done a remarkable amount of quiet damage.
The part that makes it work: knowing when
Getting ahead of pain requires one thing that treating pain doesn’t: knowing when your period is coming.
This is the piece that used to make the whole approach impractical, and it’s the piece that has genuinely changed. If you track your cycle — even simply, even just marking day one each month — you build the forecast you need. A few cycles of data is usually enough to see your own pattern, including how much your cycle length actually varies.
That’s why proactive care and cycle tracking aren’t two separate habits. They’re one habit. The tracking is what makes the timing possible.
What else has evidence behind it
Two non-pharmaceutical approaches have real support and are worth knowing about.
Physical activity. A systematic review and meta-analysis of randomized controlled trials found physical activity effective for primary menstrual pain, with positive trials across aerobic exercise, yoga, and stretching programs. This is one of the better-supported non-drug interventions available.
Heat. Continuous, low-level topical heat has been tested in randomized trials, including head-to-head against common oral analgesics, and performs well. The heating pad is not a folk remedy. It’s an evidence-backed intervention.
In the interest of being straight with you: dietary supplements for menstrual pain have been reviewed by Cochrane, and the evidence is limited and largely low quality. Some individual trials look promising. The overall picture doesn’t yet support confident recommendations. We’d rather tell you that than sell you a maybe.
A few honest caveats
Medications that inhibit prostaglandin synthesis are generally well tolerated when used for a few days a month by otherwise healthy young people, but they aren’t right for everyone — certain medical histories, medication interactions, and stomach conditions all matter. They’re typically taken with food to reduce gastrointestinal irritation. Read the label, and talk to a clinician if you have any reason to think you might be an exception.
And here’s a piece of guidance worth holding onto: if you’ve genuinely tried this approach for two to three cycles and your pain still isn’t controlled, that’s not a personal failure. That’s clinical information. Pain that doesn’t respond well to standard treatment is one of the signals that something else may be going on — which is exactly what our next post is about.
The shift
The change we’re arguing for is small in practice and large in effect. Instead of responding to pain once it has established itself, you act in the window before it starts, when the chemistry driving it can still be interrupted.
That’s it. Same intent, different timing, meaningfully different month.
Wave Bye is built around this idea — a non-hormonal, over-the-counter medication designed to be taken before your period begins, paired with the tracking that tells you when “before” is. Not a new theory. Just the timing that the science has pointed at all along, made into something you can actually do.
Ready to plan around your cycle, not just react to it?
In a new-patient visit, we’ll look at your history together and build a proactive plan: what to take, when to take it, and what would mean it’s time to look further.
Book a VisitMedical review & sources
This article is based on pharmacologic and clinical evidence on pre-emptive NSAID use for primary dysmenorrhea, including timing-of-administration trials, intrauterine pressure measurements, and Cochrane reviews of non-pharmacologic interventions. It is for education only and is not medical advice; it does not replace an evaluation by your own clinician.
Medically reviewed by Margo Harrison, MD, MPH, FACOG · Last updated August 2026

